Skip to main content
. 2017 Nov 3;15:226. doi: 10.1186/s12967-017-1329-y

Fig. 1.

Fig. 1

Drug approvals in 2012–2016. a Approvals in percent of total analyzed drugs as per therapeutic area. b US Drug approvals as per year. Primary y-axis (continuous lines): approval in percent of total US approvals as per year, secondary y-axis (broken line): total numbers of US approvals as per year